Trial Profile
Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2020
Price :
$35
*
At a glance
- Drugs Bepotastine/corticosteroid (Primary) ; Bepotastine; Corticosteroid
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
- 04 Jan 2013 Lead trial centre added as reported by ClinicalTrials.gov.
- 15 Aug 2012 Actual end date (Aug 2012) added as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.